
Pembrolizumab (Keytruda) in Combination With Lenvatinib (Lenvima)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - English
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.451
Subject(s) - pembrolizumab , lenvatinib , medicine , endometrial cancer , oncology , microsatellite instability , docetaxel , systemic therapy , chemotherapy , cancer , immunotherapy , breast cancer , allele , biochemistry , chemistry , thyroid cancer , microsatellite , gene